Biopsy is the surgical removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissue. Biopsy procedures can be performed for almost any organ with the help of a specific biopsy device. Conventional biopsy devices can be complemented with advanced imaging technologies such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others to perform a biopsy procedure with accuracy and minimal invasiveness. These integrated procedures are important to perform biopsies in critical areas of the body such as the lungs, liver, and kidney.
Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements have been stimulating the growth of the biopsy devices market. Moreover, increase in awareness for the diagnosis of chronic diseases such as breast cancer and lung cancer is also increasing the demand for integrated biopsy technologies such as MRI-guided biopsy. On the contrary, the use of advanced biopsy devices in developing countries is still restricted due to high cost, unawareness for the diagnosis of chronic diseases, and lack of technical expertise. However, companies are now concentrating on developing cost-effective biopsy devices, which would decrease the overall cost of biopsy procedures.
The report segments the world biopsy devices market by device type, application, biopsy procedures, imaging technologies, end users, and geography. The types of devices profiled in this report include breast biopsy devices, gastrointestinal (GI) biopsy devices, soft tissue biopsy devices, bronchial biopsy devices, gynaecological biopsy devices, robotic biopsy devices, and other devices. Based on application, the report is segmented into breast biopsy, gastrointestinal (GI) biopsy, prostate, liver, lung, kidney, gynaecological, and others. End users for the biopsy devices market comprise hospitals and diagnostic centers. Geographically, the world biopsy devices market is segmented across North America, Europe, Asia-Pacific, and LAMEA.
Product launches was the most preferred strategy followed by collaborations & geographic expansion for market capitalization. The report provides a comprehensive analysis of the leading companies operating in the world biopsy devices market. The key companies profiled in the report are C.R. Bard, Inc., Leica Biosystems, Hologic, Inc., Becton, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Mauna Kea Technologies, Cook Medical, Inc., Medtronic, Argon Medical Devices, Inc, Intact Medical Corp., and others.
KEY BENEFITS FOR STAKEHOLDERS:
BIOPSY DEVICES MARKET KEY SEGMENTS:
By Device Type
By Imaging Technology
By End User
SIMILAR MARKET STUDIES
United Kingdom Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitoring and Patient Monitoring Accessories
United Kingdom Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitoring and Patient Monitoring Accessories Summary GlobalData’s new report, "United Kingdom Healthcare IT Market Outlook to 2022", provides key market data on ...
November 2016 | $5995 | View Details >>
2016 Global Critical Care Equipment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Critical Care Equipment industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced ...
September 2016 | $2850 | View Details >>
The Global Transfusion Diagnostic Testing Analyzers Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Transfusion Diagnostic Testing Analyzers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Transfusion Diagnostic Testing Analyzers market ...
November 2015 | $2800 | View Details >>
Summary Vancive Medical Technologies (Vancive), formerly Avery Dennison Medical Solutions is a subsidiary of Avery Dennison Corporation, medical device company that uses pressure-sensitive adhesive and material technologies. The company's products offering include converted hydrocolloids, hydrocolloid transfer tape, non woven tapes, and others. Its technologies include intelishield barrier film, metria informed health, ...
September 2016 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research